These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 19645490)

  • 1. Substrate binding mechanism of HIV-1 protease from explicit-solvent atomistic simulations.
    Pietrucci F; Marinelli F; Carloni P; Laio A
    J Am Chem Soc; 2009 Aug; 131(33):11811-8. PubMed ID: 19645490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of conformational fluctuations in the enzymatic reaction of HIV-1 protease.
    Piana S; Carloni P; Parrinello M
    J Mol Biol; 2002 May; 319(2):567-83. PubMed ID: 12051929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into a mutation-assisted lateral drug escape mechanism from the HIV-1 protease active site.
    Sadiq SK; Wan S; Coveney PV
    Biochemistry; 2007 Dec; 46(51):14865-77. PubMed ID: 18052195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding pathways of ligands to HIV-1 protease: coarse-grained and atomistic simulations.
    Chang CE; Trylska J; Tozzini V; McCammon JA
    Chem Biol Drug Des; 2007 Jan; 69(1):5-13. PubMed ID: 17313452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A molecular dynamics study comparing a wild-type with a multiple drug resistant HIV protease: differences in flap and aspartate 25 cavity dimensions.
    Seibold SA; Cukier RI
    Proteins; 2007 Nov; 69(3):551-65. PubMed ID: 17623840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Explicit solvent dynamics and energetics of HIV-1 protease flap opening and closing.
    Sadiq SK; De Fabritiis G
    Proteins; 2010 Nov; 78(14):2873-85. PubMed ID: 20715057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free energy calculations on dimer stability of the HIV protease using molecular dynamics and a continuum solvent model.
    Wang W; Kollman PA
    J Mol Biol; 2000 Nov; 303(4):567-82. PubMed ID: 11054292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flap opening mechanism of HIV-1 protease.
    Tóth G; Borics A
    J Mol Graph Model; 2006 May; 24(6):465-74. PubMed ID: 16188477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How inaccuracies in protein structure models affect estimates of protein-ligand interactions: computational analysis of HIV-I protease inhibitor binding.
    Thorsteinsdottir HB; Schwede T; Zoete V; Meuwly M
    Proteins; 2006 Nov; 65(2):407-23. PubMed ID: 16941468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of the HIV-1 resistance development: enzymatic activities, crystal structures, and thermodynamics of nelfinavir-resistant HIV protease mutants.
    Kozísek M; Bray J; Rezácová P; Sasková K; Brynda J; Pokorná J; Mammano F; Rulísek L; Konvalinka J
    J Mol Biol; 2007 Dec; 374(4):1005-16. PubMed ID: 17977555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the role of the R configuration of the reaction-intermediate isostere in HIV-1 protease-inhibitor binding: X-ray structure at 2.0 A resolution.
    Dusková J; Dohnálek J; Skálová T; Petroková H; Vondrácková E; Hradílek M; Konvalinka J; Soucek M; Brynda J; Fábry M; Sedlácek J; Hasek J
    Acta Crystallogr D Biol Crystallogr; 2006 May; 62(Pt 5):489-97. PubMed ID: 16627941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding free energy contributions of interfacial waters in HIV-1 protease/inhibitor complexes.
    Lu Y; Yang CY; Wang S
    J Am Chem Soc; 2006 Sep; 128(36):11830-9. PubMed ID: 16953623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coarse-grained molecular dynamics of ligands binding into protein: The case of HIV-1 protease inhibitors.
    Li D; Liu MS; Ji B; Hwang K; Huang Y
    J Chem Phys; 2009 Jun; 130(21):215102. PubMed ID: 19508101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular dynamics and free energy studies on the wild-type and mutated HIV-1 protease complexed with four approved drugs: mechanism of binding and drug resistance.
    Alcaro S; Artese A; Ceccherini-Silberstein F; Ortuso F; Perno CF; Sing T; Svicher V
    J Chem Inf Model; 2009 Jul; 49(7):1751-61. PubMed ID: 19537723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular dynamics and free energy studies on the wild-type and double mutant HIV-1 protease complexed with amprenavir and two amprenavir-related inhibitors: mechanism for binding and drug resistance.
    Hou T; Yu R
    J Med Chem; 2007 Mar; 50(6):1177-88. PubMed ID: 17300185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Wide-open" 1.3 A structure of a multidrug-resistant HIV-1 protease as a drug target.
    Martin P; Vickrey JF; Proteasa G; Jimenez YL; Wawrzak Z; Winters MA; Merigan TC; Kovari LC
    Structure; 2005 Dec; 13(12):1887-95. PubMed ID: 16338417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Closing of the flaps of HIV-1 protease induced by substrate binding: a model of a flap closing mechanism in retroviral aspartic proteases.
    Tóth G; Borics A
    Biochemistry; 2006 May; 45(21):6606-14. PubMed ID: 16716071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the substrate envelope hypothesis for inhibitors of HIV-1 protease.
    Chellappan S; Kairys V; Fernandes MX; Schiffer C; Gilson MK
    Proteins; 2007 Aug; 68(2):561-7. PubMed ID: 17474129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An ethylenamine inhibitor binds tightly to both wild type and mutant HIV-1 proteases. Structure and energy study.
    Skálová T; Hasek J; Dohnálek J; Petroková H; Buchtelová E; Dusková J; Soucek M; Majer P; Uhlíková T; Konvalinka J
    J Med Chem; 2003 Apr; 46(9):1636-44. PubMed ID: 12699382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural parameterization of the binding enthalpy of small ligands.
    Luque I; Freire E
    Proteins; 2002 Nov; 49(2):181-90. PubMed ID: 12210999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.